For Generic Vancocin, An Advisory Committee Role Reversal

FDA will essentially play the part of a sponsor during the Aug. 4 pharmaceutical science panel meeting, arguing for favorable approval standards, while the brand sponsor, ViroPharma, will play the role of skeptic.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet